Table 3.2. Clients in treatment, by type
of care received, and clients receiving methadone or buprenorphine: 2007-20111 Number and percent distribution |
||||||||||
Type of care received and clients
receiving methadone or buprenorphine |
Number of clients | Percent distribution | ||||||||
2007 | 2008 | 2009 | 2010 | 2011 | 2007 | 2008 | 2009 | 2010 | 2011 | |
Total | 1,135,425 | 1,192,490 | 1,182,077 | 1,175,462 | 1,224,127 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
Type of care received | ||||||||||
Outpatient | 1,016,913 | 1,071,572 | 1,064,562 | 1,056,532 | 1,095,897 | 89.6 | 89.9 | 90.1 | 89.9 | 89.5 |
Regular | 595,459 | 644,009 | 598,282 | 593,077 | 617,715 | 52.4 | 54.0 | 50.6 | 50.5 | 50.5 |
Intensive | 132,977 | 130,260 | 147,132 | 138,188 | 141,964 | 11.7 | 10.9 | 12.4 | 11.8 | 11.6 |
Detoxification | 12,705 | 11,339 | 10,786 | 13,216 | 13,450 | 1.1 | 1.0 | 0.9 | 1.1 | 1.1 |
Day treatment/partial hospitalization | 22,297 | 22,835 | 23,822 | 22,458 | 23,338 | 2.0 | 1.9 | 2.0 | 1.9 | 1.9 |
Methadone maintenance | 253,475 | 263,129 | 284,540 | 289,593 | 299,430 | 22.3 | 22.1 | 24.1 | 24.6 | 24.5 |
Residential (non-hospital) | 103,709 | 107,441 | 103,174 | 103,692 | 112,827 | 9.1 | 9.0 | 8.7 | 8.8 | 9.2 |
Detoxification | 7,536 | 6,746 | 6,067 | 7,549 | 9,326 | 0.7 | 0.6 | 0.5 | 0.6 | 0.8 |
Short-term treatment (30 days or fewer) | 24,171 | 25,566 | 25,807 | 26,014 | 29,164 | 2.1 | 2.1 | 2.2 | 2.2 | 2.4 |
Long-term treatment (more than 30 days) | 72,002 | 75,129 | 71,300 | 70,129 | 74,337 | 6.3 | 6.3 | 6.0 | 6.0 | 6.1 |
Hospital inpatient | 14,803 | 13,477 | 14,341 | 15,238 | 15,403 | 1.3 | 1.1 | 1.2 | 1.3 | 1.3 |
Detoxification | 6,319 | 5,686 | 6,427 | 6,476 | 6,179 | 0.6 | 0.5 | 0.5 | 0.6 | 0.5 |
Treatment | 8,484 | 7,791 | 7,914 | 8,762 | 9,224 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 |
Clients receiving methadone or buprenorphine | ||||||||||
Total | 266,031 | 283,803 | 308,781 | 327,099 | 340,456 | 23.4 | 23.8 | 26.1 | 27.8 | 27.8 |
Clients receiving methadone | 262,684 | 268,071 | 284,608 | 299,643 | 307,780 | 23.1 | 22.5 | 24.1 | 25.5 | 25.1 |
Clients receiving buprenorphine2 | 3,347 | 15,732 | 24,173 | 27,456 | 32,676 | 0.3 | 1.3 | 2.0 | 2.3 | 2.7 |
1 Survey reference dates were March 30, 2007, and March 31, 2008-2011. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. | ||||||||||
2 Non-OTP buprenorphine clients were not included in 2007. | ||||||||||
NOTE: Percentages may not sum to 100 percent because of rounding. | ||||||||||
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2007-2011. |